PHIP as a Therapeutic Target for Driver-Negative Subtypes of Melanoma, Breast, and Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1804779115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple Negative Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Neuropilin-1 as Therapeutic Target for Malignant Melanoma

Frontiers in Oncology
Cancer ResearchOncology
2015English

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

O1-19-1Characterization of URST1 as a Biomarker and Therapeutic Target for Lung Cancer and Oral Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Molecular Stratification Within Triple-Negative Breast Cancer Subtypes

Scientific Reports
Multidisciplinary
2019English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy